Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2: Renal study

Gatta, 2014, Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study, Lancet Oncol, 15, 35, 10.1016/S1470-2045(13)70548-5 Geenen, 2007, Medical assessment of adverse health outcomes in long-term survivors of childhood cancer, J Am Med Assoc, 297, 2705, 10.1001/jama.297.24.2705 Jones, 2008, Children's Oncology G. Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group, Pediatr Blood Cancer, 51, 724, 10.1002/pbc.21695 Kooijmans, 2019, Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer, Cochrane Database Syst Rev, 3 O'Sullivan, 2016, Late effects of chemotherapeutic agents on renal function in childhood cancer survivors: a review of the literature, Ir J Med Sci Breitz, 2004, Clinical aspects of radiation nephropathy, Cancer Biother Radiopharm, 19, 359, 10.1089/1084978041425106 de Graaf, 1996, Renal function after unilateral nephrectomy for Wilms' tumour: the influence of radiation therapy, Eur J Cancer, 32A, 465, 10.1016/0959-8049(95)00618-4 Oberlin, 2009, Long-term evaluation of Ifosfamide-related nephrotoxicity in children, J Clin Oncol: Official J Am Soc Clin Oncol, 27, 5350, 10.1200/JCO.2008.17.5257 Skinner, 2009, Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors, Eur J Cancer (Oxford, England: 1990), 45, 3213, 10.1016/j.ejca.2009.06.032 Dekkers, 2013, Long-term nephrotoxicity in adult survivors of childhood cancer, Clin J Am Soc Nephrol : CJASN, 8, 922, 10.2215/CJN.09980912 Kannel, 1996, Blood pressure as a cardiovascular risk factor: prevention and treatment, JAMA, 275, 1571, 10.1001/jama.1996.03530440051036 Gibson, 2017, Blood pressure status in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study, Cancer Epidemiol Biomark Prev : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 26, 1705, 10.1158/1055-9965.EPI-17-0510 Meacham, 2011, Longitudinal assessment of cardiovascular risk factors (CVRF) in adult survivors of pediatric cancer: a report from the childhood cancer survivor study (CCSS). Conference Abstract, Hormone Res Paediatr, 76, 34 Knijnenburg, 2012, Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors, Clin J Am Soc Nephrol: CJASN, 7, 1416, 10.2215/CJN.09620911 Green, 2020, Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study, Pediatr Blood Cancer, 10.1002/pbc.28271 Geenen, 2010, Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy, Pediatr Blood Cancer, 55, 690, 10.1002/pbc.22518 Hoffmeister, 2010, Hypertension in long-term survivors of pediatric hematopoietic cell transplantation, Biol Blood Marrow Transplant : J Am Soc Blood and Marrow Transplant, 16, 515, 10.1016/j.bbmt.2009.11.018 Williams, 2018, 2018 ESC/ESH Guidelines for the management of arterial hypertension, Eur Heart J, 39, 3021, 10.1093/eurheartj/ehy339 de la Sierra, 2012, Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study, J Hypertens. Apr, 30, 713, 10.1097/HJH.0b013e328350bb40 Dolan, 2005, Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study, Hypertens (Dallas, Tex : 1979), 46, 156, 10.1161/01.HYP.0000170138.56903.7a Minutolo, 2011, Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease, Arch Intern Med, 171, 1090, 10.1001/archinternmed.2011.230 Elli, 2013, The late effects of anticancer therapy after childhood Wilm's tumor: the role of diastolic function and ambulatory blood pressure monitoring, Jpn J Clin Oncol, 43, 1004, 10.1093/jjco/hyt105 McMahon, 2018, Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study, Pediatr Nephrol, 33, 2311, 10.1007/s00467-018-3976-5 Guler, 2018, Prevalence of hypertension determined by ambulatory blood pressure monitoring (ABPM) and body composition in long-term survivors of childhood cancer, Pediatr Hematol Oncol, 35, 1, 10.1080/08880018.2018.1425784 Ociepa, 2019, Prevalence and risk factors for arterial hypertension development in childhood ALL survivors, J pediatr hematol/oncol, 41, 175, 10.1097/MPH.0000000000001349 Chu, 2021, Kidney outcomes and hypertension in survivors of Wilms tumor: a prospective cohort study, J Pediatr, 230, 215, 10.1016/j.jpeds.2020.12.005 Kamps, 1999, Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991), Blood, 94, 1226 Kamps, 2002, BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996), Leukemia, 16, 1099, 10.1038/sj.leu.2402489 Scholtens, 2015, Cohort Profile: LifeLines, a three-generation cohort study and biobank, Int J Epidemiol, 44, 1172, 10.1093/ije/dyu229 O'Brien, 2013, European Society of Hypertension position paper on ambulatory blood pressure monitoring, J Hypertens, 31, 1731, 10.1097/HJH.0b013e328363e964 Inker, 2012, Estimating glomerular filtration rate from serum creatinine and cystatin C, N Engl J Med, 367, 20, 10.1056/NEJMoa1114248 Grubb, 2010, First certified reference material for cystatin C in human serum ERM-DA471/IFCC, Clinical Chem Lab Med, 48, 1619, 10.1515/CCLM.2010.318 2013, KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease, Kidney Int Suppl, 3, 1 Blokstra, 2011 Bates, 2019, Therapy-related cardiac risk in childhood cancer survivors: an analysis of the Childhood Cancer Survivor Study, J Clin Oncol: Official J Am Soc Clin Oncol, 37, 1090, 10.1200/JCO.18.01764 Chow, 2013, Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries, Jama, 310, 959, 10.1001/jama.2013.184182 Armstrong, 2013, Modifiable risk factors and major cardiac events among adult survivors of childhood cancer, J Clin Oncol: Official J Am Soc Clin Oncol, 31, 3673, 10.1200/JCO.2013.49.3205 Green, 2021, Kidney function after treatment for childhood cancer: a report from the St. Jude Lifetime Cohort Study, J Am Soc Nephrol : JASN, 2, 983, 10.1681/ASN.2020060849 Dieffenbach, 2021, Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study, Eur J Cancer (Oxford, England: 1990), 155, 216, 10.1016/j.ejca.2021.06.050 Cardous-Ubbink, 2010, Hypertension in long-term survivors of childhood cancer: a nested case-control study, Eur J Cancer (Oxford, England: 1990), 46, 782, 10.1016/j.ejca.2010.01.002 Thakkar, 2020, Masked hypertension: a systematic review, Heart, Lung Circulation, 29, 102, 10.1016/j.hlc.2019.08.006 Parati, 2016, Hypertension in chronic kidney disease part 2: role of ambulatory and home blood pressure monitoring for assessing alterations in blood pressure variability and blood pressure profiles, Hypertension (Dallas, Tex: 1979), 67, 1102, 10.1161/HYPERTENSIONAHA.115.06896